We use cookies to ensure that we give you the best experience on our website.

Cookies Notice

WHAT IS COOKIE?

A cookie is a small piece of text that allows a website to recognize your device and maintain a consistent, cohesive experience throughout multiple sessions. If you visit EDAN pages, both EDAN and third parties will use cookies to track and monitor some of your activities, and store and access some data about you, your browsing history, and your usage of the EDAN pages.


HOW DOES EDAN USE COOKIES?

This policy describes how both EDAN and other third parties use cookies and how you can exercise a greater degree of control over cookies. Please keep in mind that this may alter your experience with our website, and may limit certain features.


General Browsing: We use cookies that are important for certain technical features of our website, like implementing fixes and improvements to our platform.

These cookies:

    - Enable behavior in our Products or Services that is tailored to the activity or preferences of a person visiting our properties

    - Allow users to opt out of certain types of modeling or personalization in our products

    - Collect information on our users’ preferences in order to create more useful products

    - Maintain the regular business operations of our Advertising and Marketing departments

    - Help to diagnose and correct downtime, bugs, and errors in our code to ensure that our products are operating efficiently


Analytics: We use cookies to compile usage activity in order to better cater our Products and Services offerings to you, and to third parties. We DO NOT share identifiable “raw” data with our clients or any third parties, however we do make high-level decisions based on aggregated data about your usage of our Products and Services.


These cookies:

    - Monitor site traffic and behavior flows of users

    - Measure the effectiveness of products

    - Measure the effectiveness of off-site marketing campaigns and tactics


WHAT INFORMATION IS COLLECTED ON ME VIA COOKIES?

In general, we collect most data from you via form submission. However, there are cases when visiting our site and/or using our platforms in which we may receive certain information through the use of cookies. This data will generally not include personally identifying information about you.

    - Unique identification tokens

    - User preferences such as favorite tags (for anonymous users only)


Third Party Cookies

The use of cookies, the names of cookies, and other cookies related cookies technology may change over time and EDAN will make all reasonable efforts to notify you by updating our cookies table where material changes occur and from time-to-time.


HOW DO I RESTRICT COOKIES?

If you don’t want EDAN to use cookies when you visit EDAN home pages, you can opt-out of certain cookie related processing activities when you visit the pages. If you opt-out of cookies, we have to set a cookie to tell us that. Please note that EDAN may not work properly and you may have diminished functionality if you opt-out of certain cookies.If you decide that you do not want cookies to be set on your device by our third-party Partners, you can adjust the settings on your internet browser and choose from the available Cookies setting to best meet your preferences. While setting options may vary from browser to browser, you can generally choose to reject some or all cookies, or instead to receive a notification when a cookie is being placed on your device. For more information, please refer to the user help information for your browser of choice. Please keep in mind that cookies may be required for certain functionalities, and by blocking these cookies, you may limit your access to certain parts or features of our sites. You can manually delete the cookies at any time.

选择另一个国家或地区,以获得适用于你所在位置的内容和在线购物选项。
中文
继续
Company News Exhibitions & Events COVID-19 Product Insights

EDAN Forays into Molecular Point-of-Care Market with Its First-Ever Molecular Diagnostics Solution Released at Medlab Asia 2022

10.19-2022

Developed based on Loop-Mediated Isothermal Amplification (LAMP), the new molecular diagnostics analysis system, ClariLight CL30, gives on-the-spot results and empowers physicians for early infectious disease diagnostics because of its agility, fast, and flexibility.

 

BANGKOK, Thailand, Oct. 19, 2022 /PRNewswire/ --  EDAN Instruments, Inc. (300206.SZ) showcased its first molecular diagnostics analysis system, ClariLight CL30, at Medlab Asia & Asia Health 2022, announcing its start of a new segment in diagnostics applications. On this ASEAN region’s leading exhibition, CL30 made its worldwide debut at Booth 6.D19, and a series of live demonstrations were held at IMPACT Exhibition Center, Bangkok, Thailand, Oct 19-21.


“The advent of ClariLight CL30 scales up our product portfolio in diagnostics applications. As the fastest-growing segment of In-Vitro diagnostics, the development of molecular diagnostics is of strategic significance for EDAN. And we are well geared to grasp its prospective growth." Remarked on by Alex You, Senior Director of EDAN Global Marketing & Strategic Operations.


EDAN CL30 on Medlab Asia & Asia Health.jpg


EDAN showed its determination through a series of industrial layouts to face the challenge in the rapidly growing molecular diagnostic market, including previously acquiring the ClariLight molecular diagnostics point of care (POC) platform of LGC, a global life science tools leader from the United Kingdom.


The new system is designed to offer effective solutions for infectious disease diagnostics by reducing the window period. Unlike PCR-based methods (generally non-portable, laboratory setting, time-consuming), CL30 produces molecular results as quick as 15 minutes, while multi-parameters cartridges and the extraction-free procedure allow massive and rapid molecular tests feasible.

 

Respiratory infection control is an issue of global concern, and pathogen identification is important for identifying and containing potential outbreaks. The analytes(SARS-CoV-2, Influenza A/B, Influenza A/B & SARS-CoV-2, Influenza A/B & RSV) on CL30 are tailored to the typical respiratory infections.


“CL30 renders accurate and effective results,” Said Alex, “It helps to achieve patient-tailored interventions and therapeutics. The plan is taking shape and we expect to do more.”


For further information, visit https://www.edan.com/product/poct/.